SUNPHARMA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sun Pharmaceutical Industries Ltd

Watchlist Manager

Watchlist

Price: 1 873.2 INR 1.95% Market Closed

Market Cap: ₹4.5T

	Sun Pharmaceutical Industries Ltd NSE:SUNPHARMA	IN
	Orange SA OTC:ORANY	FR
C	China Petroleum & Chemical Corp DUS:CHU	CN

Profitability Summary

Sun Pharmaceutical Industries Ltd's profitability score is 63/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

80%

Strong 3Y Average Gross Margin

78%

Gross Margin is Increasing

77% > 80%

Healthy Operating Margin

23%

Sustainable 3Y Average Operating Margin

23%

Operating Margin is Increasing

22% > 23%

Healthy Net Margin

20%

Sustainable 3Y Average Net Margin

20%

Net Margin is Increasing

19% > 20%

Exceptional Free Cash Flow Margin

15%

Strong 3Y Average Free Cash Flow Margin

19%

Free Cash Flow Margin is Increasing

8% > 15%

Positive ROE

16%

Positive 3Y Average ROE

Positive 3Y Average ROIC

16%

ROIC is Increasing

16% > 16%

View All

Hide

Collapse

63 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.